Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Long-Term Deferred Tax (2016 - 2026)

Avanos Medical's Long-Term Deferred Tax history spans 12 years, with the latest figure at $33.1 million for Q4 2025.

  • On a quarterly basis, Long-Term Deferred Tax rose 32.93% to $33.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $33.1 million, a 32.93% increase, with the full-year FY2025 number at $33.1 million, up 32.93% from a year prior.
  • Long-Term Deferred Tax hit $33.1 million in Q4 2025 for Avanos Medical, up from $25.3 million in the prior quarter.
  • Over the last five years, Long-Term Deferred Tax for AVNS hit a ceiling of $61.9 million in Q2 2021 and a floor of $4.3 million in Q3 2023.
  • Historically, Long-Term Deferred Tax has averaged $16.1 million across 5 years, with a median of $11.0 million in 2022.
  • Biggest five-year swings in Long-Term Deferred Tax: soared 342.14% in 2021 and later tumbled 82.07% in 2022.
  • Tracing AVNS's Long-Term Deferred Tax over 5 years: stood at $10.0 million in 2021, then plummeted by 54.0% to $4.6 million in 2022, then surged by 41.3% to $6.5 million in 2023, then skyrocketed by 283.08% to $24.9 million in 2024, then skyrocketed by 32.93% to $33.1 million in 2025.
  • Business Quant data shows Long-Term Deferred Tax for AVNS at $33.1 million in Q4 2025, $25.3 million in Q3 2025, and $25.3 million in Q2 2025.